Zura Bio (STU:94E) Days Sales Outstanding : 0.00 (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Days Sales Outstanding?

Zura Bio's average Accounts Receivable for the three months ended in Mar. 2025 was €0.00 Mil. Zura Bio's Revenue for the three months ended in Mar. 2025 was €0.00 Mil.

The historical rank and industry rank for Zura Bio's Days Sales Outstanding or its related term are showing as below:

STU:94E's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 70.81
* Ranked among companies with meaningful Days Sales Outstanding only.

Zura Bio's Days Sales Outstanding stayed the same from Mar. 2024 (0.00) to Mar. 2025 (0.00).

Zura Bio Days Sales Outstanding Historical Data

The historical data trend for Zura Bio's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Days Sales Outstanding Chart

Zura Bio Annual Data

Trend

Mar22

Dec23

Dec24

Days Sales Outstanding

Zura Bio Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Zura Bio's Days Sales Outstanding

For the Biotechnology subindustry, Zura Bio's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zura Bio's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zura Bio's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zura Bio's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Zura Bio Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zura Bio's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Zura Bio's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Zura Bio (STU:94E) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Zura Bio Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zura Bio's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Zura Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ZURA:USA

Address

1489 W. Warm Springs Road, Suite 110, Henderson, NV, USA, 89014

Website

https://www.zurabio.com

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Zura Bio Headlines

No Headlines